{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:56:40Z","timestamp":1778821000029,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115369"],"award-info":[{"award-number":["115369"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1002\/jps.24485","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T18:57:02Z","timestamp":1431975422000},"page":"2986-2997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Two-Stage Single-Compartment Models to Evaluate Dissolution in the Lower Intestine"],"prefix":"10.1016","volume":"104","author":[{"given":"Constantinos","family":"Markopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vertzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Symillides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippos","family":"Kesisoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Reppas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.24485_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/mp800261a","article-title":"Toward an increased understanding of the barriers to colonic drug absorption in humans: Implications for early controlled release candidate assessment","volume":"6","author":"Tannergren","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.24485_bb0010","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/jps.24485_bb0015","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-009-9927-x","article-title":"Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults","volume":"26","author":"Diakidou","year":"2009","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24485_bb0020","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s11095-010-0158-y","article-title":"Characterization of the ascending colon fluids in ulcerative colitis","volume":"27","author":"Vertzoni","year":"2010","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24485_bb0025","unstructured":"Reppas C, Goumas C, Markopoulos C, Karatza E, Vertzoni M. Characterization of contents of distal ileum and cecum to which drugs\/drug products are exposed during bioavailability\/bioequivalence studies in healthy adults. Pharm. Res. accepted for publication."},{"key":"10.1002\/jps.24485_bb0030","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11095-010-0223-6","article-title":"Biorelevant media to simulate fluids in the ascending colon of humans and their usefulness in predicting intracolonic drug solubility","volume":"27","author":"Vertzoni","year":"2010","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24485_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","article-title":"In vitro simulation of luminal conditions for evaluation of performance of oral drug products Choosing the appropriate test media","volume":"93","author":"Markopoulos","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.24485_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2008.06.014","article-title":"Use of the BioDis to generate a physiologically relevant IVIVC","volume":"130","author":"Klein","year":"2008","journal-title":"J Control Release"},{"key":"10.1002\/jps.24485_bb0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejps.2009.03.015","article-title":"Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form","volume":"37","author":"Jantratid","year":"2009","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1002\/jps.24485_bb0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.2042-7158.2012.01474.x","article-title":"Biorelevant in-vitro performance testing of orally administered dosage forms","volume":"64","author":"Reppas","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.24485_bb0055","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00102.2009","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1002\/jps.24485_bb0060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1211\/jpp.57.12.0006","article-title":"Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: Contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts","volume":"57","author":"Mols","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.24485_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jphp.12320","article-title":"Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: A case example","volume":"67","author":"Petrakis","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.24485_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2036.2003.01408.x","article-title":"Systematic review: The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis","volume":"17","author":"Sandborn","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/jps.24485_bb0075","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1023\/A:1018909527659","article-title":"Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: Relevance to controlled intestinal drug delivery","volume":"10","author":"French","year":"1993","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24485_bb0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0090-9556(24)15210-5","article-title":"Intestinal metabolism and transport of 5-aminosalicylate","volume":"27","author":"Zhou","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.24485_bb0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4149\/gpb_2013034","article-title":"Transintestinal transport mechanisms of 5-aminosalicylic acid (in situ rat intestine perfusion, Caco-2 cells) and biopharmaceutics classification system","volume":"32","author":"Smetanov\u00e1","year":"2013","journal-title":"Gen Physiol Biophys"},{"key":"10.1002\/jps.24485_bb0090","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1016\/j.ejmech.2009.04.018","article-title":"Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease","volume":"44","author":"Dhaneshwar","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1002\/jps.24485_bb0095","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1021\/mp100198q","article-title":"Drug solubility in luminal fluids from different regions of the small and large intestine of humans","volume":"7","author":"Fadda","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.24485_bb0100","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24485_bb0105","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1365-2036.2003.01558.x","article-title":"Combined scintigraphic and pharmacokinetic investigation of entericcoated mesalazine micropellets in healthy subjects","volume":"17","author":"Wilding","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/jps.24485_bb0110","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/jps.20063","article-title":"Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers","volume":"93","author":"Katsuma","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.24485_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2010.04.044","article-title":"The transit of dosage forms through the colon","volume":"395","author":"Wilson","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24485_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3999\/jscpt.21.377","article-title":"A study of pharmacokinetics and safety of salazosulfapyridine enteric coated tablet (PJ-306) in healthy Japanese subjects","volume":"21","author":"Uchida","year":"1990","journal-title":"Jpn J Clin Pharmacol Ther"},{"key":"10.1002\/jps.24485_bb0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12325-009-0059-9","article-title":"Pharmacokinetics and safety of single and multiple doses of Asacol tablets in Japanese healthy volunteers","volume":"26","author":"Ito","year":"2009","journal-title":"Adv Ther"},{"key":"10.1002\/jps.24485_bb0130","doi-asserted-by":"crossref","unstructured":"Pislar M, Brelih H, Bogataj M (in press) Analysis of small intestinal transit and colon arrival times on non-disintegrating tablets administered in the fasted state. Eur J Pharm Sci doi: 10.1016\/j.ejps.2015.03.001.","DOI":"10.1016\/j.ejps.2015.03.001"},{"key":"10.1002\/jps.24485_bb0135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/00365521.2014.898326","article-title":"Surface area of the digestive tract\u2014Revisited","volume":"49","author":"Helander","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1002\/jps.24485_bb0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2036.1990.tb00499.x","article-title":"Topical and systemic availability of 5-aminosalicylate: Comparisons of three controlled release preparations in man","volume":"4","author":"Christensen","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/jps.24485_bb0145","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/mp2002818","article-title":"Comparison and analysis of theoretical models for diffusion-controlled dissolution","volume":"9","author":"Wang","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.24485_bb0150","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11095-011-0594-3","article-title":"A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulations","volume":"29","author":"Bergstrand","year":"2012","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24485_bb0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpb.2008.05.029","article-title":"Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses","volume":"70","author":"Garbacz","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.24485_bb0160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/jphp.12128","article-title":"Unravelling the ultrastructure of ascending colon fluids from patients with ulcerative colitis by cryogenic transmission electron microscopy","volume":"65","author":"M\u00fcllertz","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.24485_bb0165","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s11095-006-0252-3","article-title":"Dog colonoscopy model for predicting human colon absorption","volume":"23","author":"Sutton","year":"2006","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491630079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491630079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:26:09Z","timestamp":1758360369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491630079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S002235491630079X"],"URL":"https:\/\/doi.org\/10.1002\/jps.24485","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-Stage Single-Compartment Models to Evaluate Dissolution in the Lower Intestine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/jps.24485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Wiley Periodicals, Inc. and the American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}